Targeted relief for Ménière’s disease and vestibular dysfunction
Indication:
DIZIKEY™ is indicated for the treatment of Ménière’s disease, which presents with:
* Recurrent vertigo
* Tinnitus (ringing in the ears)
* Fluctuating hearing loss
* Nausea and imbalance
Mechanism of Action:
Betahistine acts as a histamine analog with dual receptor activity:
* H1 receptor agonist: Improves microcirculation in the inner ear
* H3 receptor antagonist: Enhances vestibular compensation and suppresses abnormal vestibular signals
Clinical Advantages:
* Reduces frequency and severity of vertigo episodes
* Improves auditory clarity and balance
* Supports neural adaptation for long-term vestibular stability
* Well-tolerated with a favorable safety profile
* Enhances quality of life in chronic vestibular disorders
Note: To be used only under the guidance of a registered medical practitioner.
DIZIKEY™ — The key to unlock balance, clarity, and control.
